|70.70|| +0.02 / +0.03%|
Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates through the following segments: Life Sciences & applied markets; Diagnostics & Genomics; and Agilent CrossLab Business. The Life Sciences & Applied Markets Business segment provides application-focused solutions that include instruments, software, consumables and services that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. The Diagnostics & Genomics Business segment is comprised of five areas of activity providing solutions that include reagents, instruments, software and consumables, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab Business segment spans the entire lab with its consumables and services portfolio, which is designed to improve customer outcomes. The company was founded on May 1999 and is headquartered in Santa Clara, CA.
|Michael R. McMullen||President, Chief Executive Officer & Director|
|Kristin Giffin||Vice President-Operations, Quality & Support|
|Didier Hirsch||Chief Financial Officer & Senior Vice President|
|Darlene J. S. Solomon||Chief Technology Officer & Senior Vice President|
|Nancy Lelicoff||VP-Regulatory Affairs & Clinical Affair|